» Articles » PMID: 8668207

Differences Between MyoD DNA Binding and Activation Site Requirements Revealed by Functional Random Sequence Selection

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1996 Jul 1
PMID 8668207
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A method has been developed for selecting functional enhancer/promoter sites from random DNA sequences in higher eukaryotic cells. Of sequences that were thus selected for transcriptional activation by the muscle-specific basic helix-loop-helix protein MyoD, only a subset are similar to the preferred in vitro binding consensus, and in the same promoter context an optimal in vitro binding site was inactive. Other sequences with full transcriptional activity instead exhibit sequence preferences that, remarkably, are generally either identical or very similar to those found in naturally occurring muscle-specific promoters. This first systematic examination of the relation between DNA binding and transcriptional activation by basic helix-loop-helix proteins indicates that binding per se is necessary but not sufficient for transcriptional activation by MyoD and implies a requirement for other DNA sequence-dependent interactions or conformations at its binding site.

Citing Articles

Mechanisms of Binding Specificity among bHLH Transcription Factors.

de Martin X, Sodaei R, Santpere G Int J Mol Sci. 2021; 22(17).

PMID: 34502060 PMC: 8431614. DOI: 10.3390/ijms22179150.


Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation.

Galicia-Vazquez G, Di Marco S, Lian X, Ma J, Gallouzi I, Pelletier J PLoS One. 2014; 9(1):e87237.

PMID: 24466343 PMC: 3900710. DOI: 10.1371/journal.pone.0087237.


MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Gianakopoulos P, Mehta V, Voronova A, Cao Y, Yao Z, Coutu J J Biol Chem. 2010; 286(4):2517-25.

PMID: 21078671 PMC: 3024746. DOI: 10.1074/jbc.M110.163709.


Transcriptional regulation of selenoprotein W by MyoD during early skeletal muscle differentiation.

Noh O, Park Y, Chung Y, Kim I J Biol Chem. 2010; 285(52):40496-507.

PMID: 20956524 PMC: 3003348. DOI: 10.1074/jbc.M110.152934.


Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming.

Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez G, Parker M Dev Cell. 2010; 18(4):662-74.

PMID: 20412780 PMC: 2910615. DOI: 10.1016/j.devcel.2010.02.014.


References
1.
Blackwell T, Weintraub H . Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science. 1990; 250(4984):1104-10. DOI: 10.1126/science.2174572. View

2.
Hu J, OShea E, Kim P, Sauer R . Sequence requirements for coiled-coils: analysis with lambda repressor-GCN4 leucine zipper fusions. Science. 1990; 250(4986):1400-3. DOI: 10.1126/science.2147779. View

3.
Lin H, Yutzey K, Konieczny S . Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors. Mol Cell Biol. 1991; 11(1):267-80. PMC: 359617. DOI: 10.1128/mcb.11.1.267-280.1991. View

4.
Sun X, Baltimore D . An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell. 1991; 64(2):459-70. DOI: 10.1016/0092-8674(91)90653-g. View

5.
Wentworth B, Donoghue M, Engert J, BERGLUND E, Rosenthal N . Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci U S A. 1991; 88(4):1242-6. PMC: 50993. DOI: 10.1073/pnas.88.4.1242. View